ADC Therapeutics Email Formats

Biotechnology Research • Lausanne, Vaud, Switzerland • 201-500 Employees

ADC Therapeutics Email Formats

ADC Therapeutics uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@adctherapeutics.com), used 84.3% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@adctherapeutics.com	84.3%
{first initial}.{last name}	j.doe@adctherapeutics.com	13.8%
{first initial}	j@adctherapeutics.com	1.9%

Key Contact at ADC Therapeutics

Nicole Crawford

VP, Head of Sales

Mobile @adctherapeutics.com

Company overview

Headquarters	Lausanne, Vaud, Switzerland
Phone number	+41216530200
Website	adctherapeutics.com
NAICS	541714
SIC	873
Founded	2011
Employees	201-500
Socials

About ADC Therapeutics

ADC Therapeutics is a commercial-stage global pioneer in the field of antibody drug conjugates (ADCs). Our goal is to be a leading ADC company that transforms the lives of those impacted by cancer. We are a pioneer in the ADC field with specialized capabilities unique to ADCs from clinical to manufacturing and commercialization with a proven track record that includes an approved and marketed product. Our CD19-directed ADC ZYNLONTA® (loncastuximab tesirine-lpyl) received accelerated approval by the FDA and conditional approval from the European Commission for the treatment of relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy. ZYNLONTA is also in development in combination with other agents and in earlier lines of therapy. In addition to ZYNLONTA, ADC Therapeutics is leveraging its expertise to advance IND-enabling activities for a next-generation PSMA-targeting ADC. Founded in 2011, ADC Therapeutics is based in Lausanne, Switzerland, with operations in New Jersey. Our highly skilled global team is committed to confronting cancer with the full potential of our science and transforming the treatment paradigm for patients with cancer. For more information, please visit https://www.adctherapeutics.com/.

Employees by Management Level

Total employees: 201-500

Seniority

Employees

Entry

Director

Manager

Employees by Department

ADC Therapeutics has 143 employees across 17 departments.

Departments

Number of employees

Funding Data

Explore ADC Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2023-03-02	14	$60,000,000
2024-06-06	14	$105,000,000
2025-07-12	14	$100,000,000

Funding Insights

$265,000,000

Total funding amount

$100,000,000

Most recent funding amount

Number of funding rounds

ADC Therapeutics Tech Stack

Discover the technologies and tools that power ADC Therapeutics's digital infrastructure, from frameworks to analytics platforms.

MediaElement.js

Video players

reCAPTCHA

Security

Material Design Lite

UI frameworks

Animate.css

UI frameworks

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

Apple iCloud Mail

Webmail

HTTP/3

Miscellaneous

Flickity

JavaScript libraries

Demandbase

Analytics

Frequently asked questions

ADC Therapeutics is located in Lausanne, Vaud, CH.

You can reach ADC Therapeutics at +41216530200.

ADC Therapeutics was founded in 2011, making it 15 years old. The company has established itself as a significant player in its industry over this time.

ADC Therapeutics has approximately 201-500 employees. The company continues to grow its workforce to support its business operations and expansion.

ADC Therapeutics has raised a total of $265,000,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at ADC Therapeutics

Nicole Crawford

VP, Head of Sales

Mobile @adctherapeutics.com

4.8

40,000 users